Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 722

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 5
Chunk 722
---
389  
     11,217 
  
    Total liabilities and stockholders’ equity 
    $20,447  
    $17,047 

The accompanying notes are an integral part of
these consolidated financial statements.

F-3

INCANNEX HEALTHCARE INC.

Consolidated Statements of Operations and Comprehensive
Loss

(in thousands, except share and per share amounts)

(expressed
in U.S. Dollars, unless otherwise stated)

    For the fiscal year ended June 30, 

    2025  
    2024 
  
    Revenue from customers 
     86  
     12 
  
    Operating expenses: 

    Research and development 
     (10,747) 
     (12,879)
  
    General and administrative 
     (13,128) 
     (17,174)
  
    Total operating expenses 
     (23,875) 
     (30,053)
  
    Loss from operations 
     (23,789) 
     (30,041)
  
    Other income, net: 

    R&D tax incentive 
     1,756  
     11,434 
  
    Foreign exchange expense 
     (289) 
     (28)
  
    Interest expense 
     (303) 
     - 
  
    Interest income 
     62  
     206 
  
    Change in fair value of convertible rights 
     299  
     - 
  
    Change in fair value of warrant liabilities 
     (21,925) 
     - 
  
    Warrant issuance costs 
     (129) 
     - 
  
    Loss on extinguishment 
     (1,472) 
     - 
  
    ELOC commitment fee 
     (1,095) 
     - 
  
    Total other income, net 
     (23,096) 
     11,612 
  
    Loss before income tax expense 
     (46,885) 
     (18,429)
  
    Income tax expense 
     -  
     (30)
  
    Net loss 
    $(46,885) 
    $(18,459)
  
    Other comprehensive income/ (loss): 

    Currency translation adjustment, net of tax 
     208  
     (77)
  
    Total comprehensive loss 
    $(46,677)